1. POTENTIAL OF PHASE II TRIALS IN DRUG DEVELOPMENT Dr. Bhaswat S. Chakraborty Senior Vice President and Chairman, R&D Core Committee Cadila Pharmaceuticals Ltd. 5th…

1. EM-No. V. 01 / 2014 2. Whatever your need on Oncology Clinical Trials, ESTERN Medical CRO Group can deliver them with excellence.2 3. At ESTERN Medical, we understand…

1. What Nitro thinks ofGSK ONCOLOGY 2. OVERVIEW 3. GSK Oncology is a very attractive site. The site is a big step forward for pharma on the web.There are good aspects in…

1. Revolutionizing Vaccines Dr. J. Joseph Kim President & CEO NYSE MKT: INO 2. Forward Looking StatementOur commentary and responses to your questions may contain forward-looking…

Revolutionizing Vaccines Dr. Joseph Kim President & CEO NYSE MKT: INO Forward Looking Statement Our commentary and responses to your questions may contain forward-looking…

1. Ed Schnipper, M.D 2. Cancer Still a Major Problem • 600,000 deaths per year in US • 1,500 per day 3. Progress has been made • People living longer with cancer •…

1. Assessing the Population Representativeness of Related Clinical Trials Using Public Data Resources Zhe He1, Patrick Ryan1,2, Shuang Wang3, Chunhua Weng1 1Department of…

1. This article was downloaded by: [Amgen Inc] On: 06 August 2015, At: 11:02 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number:…

Slide 1Choosing Endpoints and Sample size considerations Methods in Clinical Cancer Research March 3, 2015 Slide 2 Sample Size and Power The most common reason statisticians…

Slide 1 Slide 2 THE UW HEALTH SCIENCES IRB S OVERVIEW PRACTICAL REGULATORY ISSUES IN HUMAN SUBJECTS RESEARCH Slide 3  The UW HS IRBs Process  Is IRB Review Needed?…